Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in MEN over 65 years of age: Results from Multiple Observations in Men with ED in National Tadalafil Study in the United States

Journal of Sexual Medicine

Volumn 5, Issue 3, 2008, Pages 716-725

  Sharlip, Ira D ^a,f   Shumaker, Bryan P ^b   Hakim, Lawrence S ^c   Goldfischer, Evan ^d   Natanegara, Fanni ^e   Wong, David G ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Michigan Institution of Urology   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Hudson Valley Urology   (United States)

^e ELI LILLY AND COMPANY   (United States)

^f Pan Pacific Urology   (United States)

Author keywords

Age aging; Efficacy; Impotence; Phosphodiesterase type 5 inhibitors; Treatment outcome

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SILDENAFIL; STEROID 5ALPHA REDUCTASE INHIBITOR; TADALAFIL;

AGED; ARTICLE; BACKACHE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RESEARCH; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; ERECTILE DYSFUNCTION; HUMAN; HUMAN RELATION; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOSE CONGESTION; OBSERVATIONAL STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; SCORING SYSTEM; SELF ESTEEM; SEXUAL INTERCOURSE; SOCIAL PSYCHOLOGY; TREATMENT DURATION; UNITED STATES;

EID: 40449132527     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2007.00712.x     Document Type: Article

References (48)